A novel nomogram and prognostic factor for metastatic renal cell carcinoma survival in the era of immune checkpoint inhibitors (ICIs)

• Hoofdauteurs: Mohammed Alradhi (Auteur), Zewen Zhang (Auteur), Mohammed Safi (Auteur), Abdullah Al-danakh (Auteur), Mokhtar Aldhbi (Auteur), Salim Baldi (Auteur), Li kui (Auteur), Abdulaziz Alradhi (Auteur), Saeed Bin Hamri (Auteur), Ka Lun lo (Auteur), Yi Zhao (Auteur), Yang Jin (Auteur)
• Formaat: Boek
• Gepubliceerd in: Frontiers Media S.A., 2023-01-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Patients with metastatic renal cell cancer (mRCC) for whom surgery is ineffective may experience a poor prognosis. The different sites where cancer has spread, and the different ways to treat it in the immune checkpoint inhibitors era could help clinical decision-making. In this study, individuals w...